BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21721061)

  • 1. Cholinesterases inhibitory and antioxidant activities of Harpagophytum procumbens from in vitro systems.
    Georgiev MI; Alipieva K; Orhan IE
    Phytother Res; 2012 Feb; 26(2):313-6. PubMed ID: 21721061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Devil's Claw (Harpagophytum procumbens) on the multidrug transporter ABCB1/P-glycoprotein.
    Romiti N; Tramonti G; Corti A; Chieli E
    Phytomedicine; 2009 Dec; 16(12):1095-100. PubMed ID: 19577448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and anti-inflammatory activity evaluation of triterpenoids and a monoterpenoid glycoside from Harpagophytum procumbens.
    Qi J; Li N; Zhou JH; Yu BY; Qiu SX
    Planta Med; 2010 Nov; 76(16):1892-6. PubMed ID: 20577946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening pharmaceutical preparations containing extracts of turmeric rhizome, artichoke leaf, devil's claw root and garlic or salmon oil for antioxidant capacity.
    Betancor-Fernández A; Pérez-Gálvez A; Sies H; Stahl W
    J Pharm Pharmacol; 2003 Jul; 55(7):981-6. PubMed ID: 12906755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality Assessment of Commercial Spagyric Tinctures of
    Avato P; Argentieri MP
    Molecules; 2019 Jun; 24(12):. PubMed ID: 31212908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects.
    Kaszkin M; Beck KF; Koch E; Erdelmeier C; Kusch S; Pfeilschifter J; Loew D
    Phytomedicine; 2004 Nov; 11(7-8):585-95. PubMed ID: 15636171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay.
    Anauate MC; Torres LM; de Mello SB
    Phytother Res; 2010 Sep; 24(9):1365-9. PubMed ID: 20812280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into cholinesterase inhibitory and antioxidant activities of five Juniperus species.
    Orhan N; Orhan IE; Ergun F
    Food Chem Toxicol; 2011 Sep; 49(9):2305-12. PubMed ID: 21708212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Devil's claw (Harpagophytum procumbens). Also known as 'grapple plant' or 'wood spider'.
    Barnes J
    J Prim Health Care; 2009 Sep; 1(3):238-9. PubMed ID: 20690389
    [No Abstract]   [Full Text] [Related]  

  • 10. Harpagoside Content in Devil's Claw Extracts.
    Kondamudi N; Turner MW; McDougal OM
    Nat Prod Commun; 2016 Sep; 11(9):1215-1216. PubMed ID: 30807002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Devil's Claw (Harpagophytum procumbens): no evidence for anti-inflammatory activity in the treatment of arthritic disease.
    Whitehouse LW; Znamirowska M; Paul CJ
    Can Med Assoc J; 1983 Aug; 129(3):249-51. PubMed ID: 6407745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iridoid glycosides from Harpagophytum procumbens D.C. (devil's claw).
    Qi J; Chen JJ; Cheng ZH; Zhou JH; Yu BY; Qiu SX
    Phytochemistry; 2006 Jul; 67(13):1372-7. PubMed ID: 16857222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inhibition of free radical generation by preparations of Harpagophytum procumbens in vitro.
    Grant L; McBean DE; Fyfe L; Warnock AM
    Phytother Res; 2009 Jan; 23(1):104-10. PubMed ID: 18803229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the major glycosides of Harpagophytum procumbens (Devil's Claw) on epidermal cyclooxygenase-2 (COX-2) in vitro.
    Abdelouahab N; Heard C
    J Nat Prod; 2008 May; 71(5):746-9. PubMed ID: 18412394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Devil's Claw-a review of the ethnobotany, phytochemistry and biological activity of Harpagophytum procumbens.
    Mncwangi N; Chen W; Vermaak I; Viljoen AM; Gericke N
    J Ethnopharmacol; 2012 Oct; 143(3):755-71. PubMed ID: 22940241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The commercial harvest of devil's claw (Harpagophytum spp.) in southern Africa: the devil's in the details.
    Stewart KM; Cole D
    J Ethnopharmacol; 2005 Sep; 100(3):225-36. PubMed ID: 16112533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholinesterase inhibitors from the roots of Harpagophytum procumbens.
    Bae YH; Cuong TD; Hung TM; Kim JA; Woo MH; Byeon JS; Choi JS; Min BS
    Arch Pharm Res; 2014; 37(9):1124-9. PubMed ID: 24374905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of devil's claw (secondary root of Harpagophytum procumbens) extract and harpagoside on cytokine production in mouse macrophages.
    Inaba K; Murata K; Naruto S; Matsuda H
    J Nat Med; 2010 Apr; 64(2):219-22. PubMed ID: 20177800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Fight against Infection and Pain: Devil's Claw (
    Gxaba N; Manganyi MC
    Molecules; 2022 Jun; 27(11):. PubMed ID: 35684573
    [No Abstract]   [Full Text] [Related]  

  • 20. Alteration of anti-inflammatory activity of Harpagophytum procumbens (devil's claw) extract after external metabolic activation with S9 mix.
    Hostanska K; Melzer J; Rostock M; Suter A; Saller R
    J Pharm Pharmacol; 2014 Nov; 66(11):1606-14. PubMed ID: 25175765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.